V

Viridian Therapeutics

Develops miRNA-targeting therapies for autoimmune diseases

Director: Patient Advocacy & Engagement

Marketing Generalist & ManagementUpdated on Nov 11
Full-time

About the Job

Requirements

  • 12+ years of experience in patient advocacy, patient engagement, patient services, patient marketing, or related healthcare functions, including direct experience within the pharmaceutical or biotechnology industry.
  • A bachelor's degree is required.
  • Deep understanding of patient advocacy organizations and demonstrated ability to build respectful, productive relationships with organizations, patients, care partners, and other community partners.
  • Demonstrated experience supporting commercial product launches and developing patient-facing educational materials or engagement initiatives.
  • Understanding of Patient Advocacy operations, MLR and PRC review processes, compliance requirements, and the regulatory environment governing advocacy organization and patient engagement.
  • Proven success leading complex cross-functional initiatives and influencing stakeholders across multiple functions and levels of the organization.
  • Proficiency with Microsoft Office, including Word, PowerPoint, Excel, Outlook, and SharePoint.
  • Ability to travel up to 30%.

Responsibilities

  • Lead the development and delivery of advocacy-related initiatives for the thyroid eye disease portfolio, with a special focus on market development and new product launches in the United States.
  • Manage internal processes that support the patient advocacy function.
  • Build, strengthen, and sustain trusted relationships with U.S.-based advocacy organizations, patients, care partners, and other stakeholders within the thyroid eye disease, vision, autoimmune, and rare disease communities.
  • Develop and own the U.S. enterprise patient advocacy strategy and annual plan for the thyroid eye disease portfolio.
  • Shape and execute commercial launch readiness activities by leading patient advocacy input into launch planning, market preparation, and stakeholder engagement workstreams, and own related deliverables.
  • Collaborate with cross-functional teams to develop educational resources, disease awareness activities, and other initiatives to support new product launches and long-term portfolio success.
  • Plan and execute community roundtables, patient advisory councils, patient listening sessions, and other engagement activities to capture community experiences, perspectives, and needs.
  • Identify and synthesize patient community insights into actionable findings, share recommendations with relevant internal teams, and champion necessary action.
  • Represent the company at patient community meetings and events.
  • Ensure interactions with advocacy organizations, patients, care partners, and community stakeholders adhere to internal and external requirements defined by local laws, regulations, and industry codes.
  • Own the U.S. thyroid eye disease patient advocacy budget, including sponsorships, grants, vendors, and consultants.
  • Manage contracting, logistics, materials development and review, participant recruitment and coordination, and follow-up for patient advocacy-run activities.
  • Oversee review, contracting, and payment of patient advocacy sponsorships, grants, and memberships.
  • Direct day-to-day relationships with consultants and vendors, ensuring accountability for scope, quality, timelines, and budget.

Desired Qualifications

  • An advanced degree in public health, healthcare, communications, social work, business, or a related field.
  • Experience applying health literacy principles and incorporating patient input into materials and programs.

About the Company

Viridian Therapeutics

Develops miRNA-targeting therapies for autoimmune diseases

Viridian Therapeutics discovers and develops therapies that target microRNA (miRNA) pathways to treat autoimmune diseases, with a focus on thyroid eye disease. The company uses monoclonal antibody technology aimed at the IGF-1 receptor (IGF-1R) pathway to modulate disease biology. Its product approach integrates miRNA biology with antibody engineering to create treatments that intervene in autoimmune processes. The company differentiates itself by combining miRNA-targeting strategies with IGF-1R–focused monoclonal antibodies, operating in the clinical-stage space and concentrating on rare thyroid-related autoimmune conditions. Its goal is to advance clinical candidates through development toward regulatory approval and eventual market launch for patients who suffer from these diseases.

Company size
201-500
Company stage
IPO
Headquarters
Waltham, MA
Founded
2007

Recently Posted Jobs

Explore more opportunities at Viridian Therapeutics

See more jobs